- $5.97bn
- $7.75bn
- BRL26.11bn
- 57
- 60
- 97
- 82
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 21,802 | 19,642 | 22,670 | 23,449 | 26,111 |
Cost of Revenue | |||||
Gross Profit | 3,157 | 2,388 | 3,498 | 4,681 | 4,465 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 22,112 | 21,323 | 21,615 | 24,004 | 24,588 |
Operating Profit | -310 | -1,681 | 1,055 | -556 | 1,523 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -741 | -3,312 | 121 | -1,063 | 559 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1,294 | -3,596 | -268 | -1,047 | 784 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -1,317 | -3,616 | -275 | -954 | 784 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1,317 | -3,616 | -275 | -954 | 784 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.72 | -4.57 | -0.141 | -0.239 | 1.03 |
Dividends per Share |